Abbott Laboratories has stopped production of the EleCare specialty baby formula at its plant in southwestern Michigan after thunderstorms and heavy rains flooded parts of the facility.
The pause announced on Wednesday marked the latest setback for the recently re-opened Sturgis plant, which has been at the center of a baby formula shortage in the United States.
The company has notified the U.S. Food and Drug Administration (FDA) and said the incident would likely delay the production and distribution of the infant formula for a few weeks. EleCare formula is meant for children and babies who cannot tolerate intact protein or may have protein allergies.
Abbott, whose shares were trading 2% lower before the bell on Thursday, had just reopened the plant last week after a product recall and months-long shutdown due to reports of bacterial infections in infants who consumed products made at the facility.
Join the conversation as a VIP Member